Recruiting
Savolitinib Plus Docetaxel as 2L in EGFR/ALK/ROS1/MET ex14m-wildtype NSCLC With MET Overexpression
NCT05777278
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Department of Thoracic Surgery and Oncology, The First Affiliated Hospital of Guangzhou Medical University Guangzhou, Guangdong, China